Home Companies Catalysts Deep Dives
ACCG-3535 ACCG-3535 PRECLINICAL
Drug Profile
ModalitySmall molecule
RouteORAL
Therapy AreaCVRM
Formulations[{"id":"accg35-oral-1","route":"ORAL","device":"Tablet","setting":"PATIENT_SELF","frequency":"Once d
Companies
GPCR (ORIGINATOR)100%
Mechanism: Dual amylin/calcitonin receptor agonist
Expert: Dual agonist targeting both amylin and calcitonin receptors, potentially providing enhanced metabolic effects through complementary receptor activation.
Everyday: A pill that activates two related hormone receptors to promote weight loss while protecting muscle and bone.
Targets: ["AMYLIN","CALCITONIN"]
Programs (1)
IndicationStageKey StudyRegional Status
ObesityPRECLINICAL—[]
Notes
Backup amylin candidate with distinct chemical structure from ACCG-2671. Provides optionality if ACCG-2671 encounters issues. Dual amylin/calcitonin receptor agonist.
Data from Supabase · Updated 2026-03-24